arrow
K

Kamran Amin

national center for nanoscience and technology and university of chinese academy of sciences and chinese academy of sciences
H指数:17
被引数:1,685
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Analysis of Asian and non-Asian patients (pts) from the NATALEE trial of ribociclib (RIB) plus a nonsteroidal aromatase inhibitor (NSAI) in pts with HR+/HER2L early breast cancer (EBC)

亚洲和非亚洲患者(pts)在NATALEE试验中,接受ribociclib(RIB)联合非甾体类芳香化酶抑制剂(NSAI)治疗人表皮生长因子受体2低表达激素受体阳性早期乳腺癌(EBC)的分析

2024-12-010
PRE